Aspect of surgery | Oestrogen (n=44) | No treatment (n=45) |
POP surgery performed | ||
Anterior repair | 35 (80%) | 34 (76%) |
Posterior repair | 16 (36%) | 19 (42%) |
Vaginal hysterectomy±bilateral salpingo-oophorectomy | 26 (59%) | 25 (56%) |
Sacrospinous fixation | 6 (14%) | 6 (13%) |
Concomitant surgery | ||
Sling/Tension-free vaginal tape | 1 (2%) | 1 (2%) |
Botulinum toxin A | 1 (2%) | 1 (2%) |
Suprapublic catheter | 1 (2%) | 1 (2%) |
Ease of dissection | ||
Very easy | 6 (14%) | 5 (11%) |
Easy | 22 (50%) | 13 (29%) |
Normal | 14 (%) | 21 (47%) |
Difficult | 2 (5%) | 5 (11%) |
Very difficult | 0 (-) | 1 (2%) |
Blood loss (g) | ||
N; median (IQR) | n=44; 63 (50–125) | n=44; 54 (50–100) |
Missing | 0 (-) | 1 (2%) |
Visceral injury | ||
Bladder injury | 0 (-) | 0 (-) |
Urethral injury | 0 (-) | 0 (-) |
Ureteric injury | 1 (2%) | 0 (-) |
Bowel injury | 0 (-) | 0 (-) |
Button hole of vagina | 3 (7%) | 1 (2%) |
Suture used—fascial plication* | ||
Polyglactin (Vicryl, Ethicon/Polysorb, Medtronic) | 10 (23%) | 10 (22%) |
Polydioxanone (PDS-II, Ethicon) | 35 (80%) | 34 (76%) |
Poligelcarprine (Monocryl, Ethicon) | 0 (-) | 0 (-) |
Missing | 0 | 1 |
Suture used—Vagina* | ||
Polyglactin (Vicryl, Ethicon/Polysorb, Medtronic) | 41 (93%) | 42 (93%) |
Polydioxanone (PDS-II, Ethicon) | 5 (11%) | 6 (13%) |
Poligelcarprine (Monocryl, Ethicon) | 3 (7%) | 1 (2%) |
Vaginal packing used | 23 (52%) | 28 (62%) |
Cather inserted in theatre | ||
Yes | 43 (98%) | 42 (93%) |
Postoperative complications noted before discharge | ||
Infection | 1 (2%) | 3 (7%) |
Ureteric injury | 0 (-) | 0 (-) |
Bladder injury | 0 (-) | 0 (-) |
Bowel injury | 0 (-) | 0 (-) |
Vascular injury | 0 (-) | 0 (-) |
Neurological injury | 0 (-) | 0 (-) |
Perioperative or postoperative blood transfusion | 0 (-) | 0 (-) |
Perioperative or postoperative thromboembolism | 0 (-) | 0 (-) |
Death | 0 (-) | 0 (-) |
*More than one can be selected, hence numbers do not add up to total.
POP, pelvic organ prolapse.